| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.07 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |